The co-injection of PMPA led to a complete suppression of 68Ga-PSMA and 18F-DCFPyL binding in the peritumoral areas of U87 and 9 L gliomas, respectively (Fig. 3), and to a reduction of tracer uptake in the center of the tumors. Here, FOLH1 is linked to central nervous system cancer.